Literature DB >> 6096149

Disturbed adrenocortical function in cerebro-hepato-renal syndrome of Zellweger.

L Govaerts, L Monnens, T Melis, F Trijbels.   

Abstract

An ACTH stimulation test was performed in six patients suffering from the cerebro-hepato-renal syndrome of Zellweger. In contrast to controls, no rise in cortisol was observed. None of these patients showed clinical symptoms of adrenal insufficiency. The sudden death, which occurs in this syndrome, can probably be explained by an impaired stress reaction. In stress situations, such as respiratory infection, corticosteroids should be administered to these patients. A striking resemblance exists between the Zwellweger syndrome and the neonatal form of adrenoleukodystrophy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096149     DOI: 10.1007/bf00442740

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Adrenoleukodystrophy. A clinical and pathological study of 17 cases.

Authors:  H H Schaumburg; J M Powers; C S Raine; K Suzuki; E P Richardson
Journal:  Arch Neurol       Date:  1975-09

2.  Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

Authors:  F R Brown; A J McAdams; J W Cummins; R Konkol; I Singh; A B Moser; H W Moser
Journal:  Johns Hopkins Med J       Date:  1982-12

3.  Biochemical studies in the liver and muscle of patients with Zellweger syndrome.

Authors:  J M Trijbels; J A Berden; L A Monnens; J L Willems; A J Janssen; R B Schutgens; M van den Broek-Van Essen
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

4.  Serum very long chain fatty acid pattern in Zellweger syndrome.

Authors:  J A Bakkeren; L A Monnens; J M Trijbels; J M Maas
Journal:  Clin Chim Acta       Date:  1984-04-27       Impact factor: 3.786

5.  Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome.

Authors:  S Goldfischer; J M Powers; A B Johnson; S Axe; F R Brown; H W Moser
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

6.  Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.

Authors:  B Molzer; H Bernheimer; R Heller; K Toifl; M Vetterlein
Journal:  Clin Chim Acta       Date:  1982-11-10       Impact factor: 3.786

7.  Cerebro-hepato-renal syndrome. Report of a case with histochemical and ultrastructural observations.

Authors:  D P Agamanolis; H B Robinson; G D Timmons
Journal:  J Neuropathol Exp Neurol       Date:  1976-05       Impact factor: 3.685

8.  Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.

Authors:  H W Moser; A B Moser; N Kawamura; J Murphy; K Suzuki; H Schaumburg; Y Kishimoto
Journal:  Ann Neurol       Date:  1980-06       Impact factor: 10.422

9.  A correlative study of the adrenal cortex in adreno-leukodystrophy--evidence for a fatal intoxication with very long chain saturated fatty acids.

Authors:  J M Powers; H H Schaumburg; A B Johnson; C S Raine
Journal:  Invest Cell Pathol       Date:  1980 Oct-Dec

10.  Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.

Authors:  H W Moser; A B Moser; K K Frayer; W Chen; J D Schulman; B P O'Neill; Y Kishimoto
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

View more
  9 in total

Review 1.  An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 2.  Peroxisomal disorders: clinical characterization.

Authors:  L Monnens; H Heymans
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy.

Authors:  B T Poll-The; J M Saudubray; H A Ogier; M Odièvre; J M Scotto; L Monnens; L C Govaerts; F Roels; A Cornelis; R B Schutgens
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

Review 4.  Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.

Authors:  R B Schutgens; R J Wanders; H S Heymans; A W Schram; J M Tager; G Schrakamp; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.

Authors:  Deyanira Corzo; William Gibson; Kisha Johnson; Grant Mitchell; Guy LePage; Gerald F Cox; Robin Casey; Carolyn Zeiss; Heidi Tyson; Garry R Cutting; Gerald V Raymond; Kirby D Smith; Paul A Watkins; Ann B Moser; Hugo W Moser; Steven J Steinberg
Journal:  Am J Hum Genet       Date:  2002-04-29       Impact factor: 11.025

6.  Further analysis of the disturbed adrenocortical function in the cerebro-hepato-renal syndrome of Zellweger.

Authors:  L Govaerts; W G Sippell; L Monnens
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 7.  Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.

Authors:  Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

8.  A milder variant of Zellweger syndrome.

Authors:  P G Barth; R B Schutgens; J A Bakkeren; K P Dingemans; H S Heymans; A C Douwes; J M van der Klei-van Moorsel
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

9.  High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders.

Authors:  Kevin Berendse; Marc Engelen; Gabor E Linthorst; A S Paul van Trotsenburg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.